<DOC>
	<DOCNO>NCT00966485</DOCNO>
	<brief_summary>The investigator prospectively studied effect aspirin platelet function 106 stable outpatient 6 month successful percutaneous coronary angioplasty . Participants randomize double-blind , double-crossover study ( 80 500 mg per day 6 month ) .T</brief_summary>
	<brief_title>Dose-related Effect Aspirin Laboratory-defined Acetylsalicylic Acid Resistance Clinical Outcome After Coronary Stenting</brief_title>
	<detailed_description>Background : Acetylsalicylic acid ( aspirin ) widely use secondary prevention coronary artery disease . There controversy regard prevalence aspirin resistance patient coronary artery disease effect dose resistance . Our primary aim determine degree platelet responsiveness aspirin , study influence dose platelet inhibition clinical outcome coronary stenting .</detailed_description>
	<criteria>6 month post stent without complication subacute stent thrombosis unable discontinue plavix dont accept participate contraindication ASA use</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>ASA resistance</keyword>
	<keyword>coronary stenting</keyword>
	<keyword>platelet function</keyword>
	<keyword>laboratory ASA resistance</keyword>
	<keyword>MACE</keyword>
	<keyword>Positive SPECT</keyword>
</DOC>